Literature DB >> 4127641

Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.

C F George, A M Breckenridge, C T Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4127641     DOI: 10.1016/s0140-6736(73)92869-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Progressive hypokalaemia in elderly patients taking three thiazide potassium-sparing diuretic combinations for thirty-six months.

Authors:  N Sawyer; R Gabriel
Journal:  Postgrad Med J       Date:  1988-06       Impact factor: 2.401

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

3.  The effects of potassium supplements, spironolactone of amiloride on the potassium status of patients with heart failure.

Authors:  C Davidson; L Burkinshaw; D B Morgan
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

4.  The effects of a combination of piretanide and triamterene in healthy subjects.

Authors:  T K Daneshmend; M Homeida; C J Roberts; S Dombey
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

5.  A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.

Authors:  D L Murdoch; G Forrest; D L Davies; G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

6.  Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.

Authors:  U G Svendsen; H Ibsen; S Rasmussen; A Leth; M D Nielsen; H Dige-Petersen; J Giese
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.

Authors:  G T McInnes; J R Shelton; R M Perkins; I R Harrison; J M Clarke
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

8.  Spironolactone in thiazide-induced hypokalaemia: variable response between patients.

Authors:  L E Ramsay; J Hettiarachchi
Journal:  Br J Clin Pharmacol       Date:  1981-02       Impact factor: 4.335

9.  Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?

Authors:  H J Dargie; K Boddy; A C Kennedy; P C King; P R Read; D M Ward
Journal:  Br Med J       Date:  1974-11-09

10.  Maximizing diuretic therapy in resistant hypertension.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.